Form D · Other
Health Outcomes Sciences, Inc.
Phoenix, AZ · CIK 0001602369
Offering snapshot reported Jun 10, 2019 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Apr 30, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 10, 2019 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
| Jun 29, 2017 | Initial | $1,885,865 | No comparison | 12 | SEC filing |
| Mar 12, 2014 | Initial | $12,750,000 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-341565
Convertible promissory notes
Source: Form D, filed Jun 10, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ralph Brindis | Director |
| Brian Burns | Director |
| Michael Fiorito | Executive |
| Matt Halle | Executive |
| Matthew Halle | Director, Executive |
| Keith Harrington | Director |
| Eve Kurtin | Director |
| Charles Mc Kay | Director |
| James Spertus | Director, Executive |
| John Spertus | Director |
| Jim Stickley | Executive |
| Matthew Wilson | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1334 E Chandler Blvd Suite 5 A21
Phoenix, AZ, 85048
Phoenix, AZ, 85048